Premium
High‐power Magnetotherapy: A New Weapon in Urinary Incontinence?
Author(s) -
VADALÀ Maria,
PALMIERI Beniamino,
MALAGOLI Andrea,
LAURINO Carmen
Publication year - 2018
Publication title -
luts: lower urinary tract symptoms
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.451
H-Index - 15
eISSN - 1757-5672
pISSN - 1757-5664
DOI - 10.1111/luts.12174
Subject(s) - nocturia , medicine , overactive bladder , urinary incontinence , urology , genitourinary system , distress , pelvic floor , quality of life (healthcare) , urination , urinary system , urodynamic testing , physical therapy , gynecology , surgery , nursing , clinical psychology , pathology , alternative medicine
Objective Urinary incontinence ( UI ) is one of the most common urinary system diseases that mostly affects women but also men. We evaluated the therapeutic efficacy of functional magnetic stimulation ( FMS ) as potential UI treatment with improvements in the pelvic floor musculature, urodynamic tests and quality of life. Methods A total of 20 UI patients (10 females and 10 men, mean age 64, 14 years), including 10 with stress UI , four with urgency UI and six with mixed UI , were treated with FMS (20 min/session) twice a week for 3 weeks. The patients' impressions, records in urinary diaries, and scores of three life stress questionnaires (overactive bladder symptom questionnaire [ OAB ‐q], urogenital distress inventory questionnaire‐short form [ UDI ‐6], incontinence impact questionnaire‐short form [ IIQ ‐7]) were performed pre‐ and post‐treatment. Results Significant reductions ( P < 0.01) of micturition number and nocturia after magnetic treatment were evidenced. The urodynamic tests recorded a significant increase in cystometric capacity (147 ± 51.3%), in maximum urethral closure pressure (110 ± 34%), in urethral functional length (99.8 ± 51.8%), and in pressure transmission ratio (147 ± 51.3%) values compared with the baseline values. Conclusions These preliminary findings suggest that FMS with M agneto STYM (twice weekly for 3 weeks) improves the UI and may be an effective treatment for this urogenital disease.